Epidemiology, Patients' Journey and Healthcare Costs in Early-Stage Non-Small-Cell Lung Carcinoma: A Real-World Evidence Analysis in Italy.

导出 OA

翻译打印收藏纠错

作者： Diego Luigi,Cortinovis ^[1] ; Valentina,Perrone ^[2] ; Elisa,Giacomini ^[2] ; Diego,Sangiorgi ^[2] ; Margherita,Andretta ^[3] ; Fausto,Bartolini ^[4] ; Giuseppe,Taurino ^[5] ; Marco,Belfiore ^[6] ; Emilia,Sicari ^[6] ; Luca,Degli Esposti ^[2]

作者单位： Division of Oncology, Department of Medicine and Surgery, San Gerardo Hospital, University of Milano-Bicocca, 20126 Monza, Italy. ^[1] CliCon S.r.l. Società Benefit, 40137 Bologna, Italy. ^[2] Unità Operativa Complessa, Assistenza Farmaceutica Territoriale, Azienda Unità Sanitaria Locale Socio Sanitaria 8 Berica, 36100 Vicenza, Italy. ^[3] Pharmaceutical Department, Unità Sanitaria Locale Umbria 2, 05100 Terni, Italy. ^[4] Pharmaceutical Department, Unità Sanitaria Locale Toscana Nord Ovest, 56121 Pisa, Italy. ^[5] Roche Spa, 20900 Monza, Italy. ^[6]

关键词 eNSCLC cancer healthcare costs real-world evidence

DOI 10.3390/ph16030363

PMID 36986463

发布时间 2023-03-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交